Cytek Biosciences (CTKB) Amortizatization of Intangibles (2022 - 2026)

Cytek Biosciences has reported Amortizatization of Intangibles for 5 years, with the latest figure at $948000.0 in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles fell 6.05% year-over-year to $948000.0; the trailing twelve-month figure through Mar 2026 stood at $4.3 million (up 22.94% YoY), and the FY2025 full-year result was $4.4 million, up 34.11% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $948000.0, down from $1.1 million in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $1.1 million in Q4 2025, with the low at $672000.0 in Q2 2024.
• Historically, Amortizatization of Intangibles has averaged $880647.1 across 5 years, with a median of $800000.0 in 2023.
• Annual changes were most pronounced in 2023 — Amortizatization of Intangibles fell 28.01% — and 2025, when it jumped 63.39%.
• Cytek Biosciences' Amortizatization of Intangibles stood at $1.1 million in 2022, then slipped by 28.01% to $794000.0 in 2023, then climbed by 11.71% to $887000.0 in 2024, then increased by 29.31% to $1.1 million in 2025, then dropped by 17.35% to $948000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $948000.0 (Q1 2026), $1.1 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.